MEDI-CAPS LTD.-$

Medi Caps Ltd has announced the closure of its trading window for all designated persons, their immediate relatives, and connected persons. The closure is effective from July 1, 2026, and will remain in effect until 48 hours after the declaration of the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The company has also confirmed compliance with recent SEBI circulars regarding trading window closures and the freezing of PAN at the security level. The exact date for the board meeting to approve these financial results will be intimated in due course.

Medi Caps Ltd announced the resignation of its Chief Financial Officer (CFO) and Key Managerial Personnel (KMP), Mr. Hemant Sethi. His resignation is effective from the close of business hours on June 6, 2026. The company cited career growth and professional opportunities as the reason for his departure. The Board of Directors has acknowledged his contributions and will formally accept the resignation at an upcoming meeting. The company will also submit the continuous disclosure in the prescribed XBRL format.

Medi Caps Ltd has re-appointed Praveen Shrivastava & Company as its Internal Auditor for the financial year 2026-27. This decision, made in compliance with the Companies Act, 2013 and SEBI (LODR) Regulations, 2015, was disclosed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The re-appointment was formalized on May 21, 2026, and is for conducting the internal audit for the fiscal year 2026-27. Praveen Shrivastava & Company is a 15-year-old firm specializing in internal audit services.

Medi Caps Ltd has submitted audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The Board of Directors approved these results at a meeting held on May 21, 2026. The board also approved the re-appointment of Praveen Shrivastava & Company as the Internal Auditor for FY 2026-27. The results and related documents will be available on the company's website and the BSE website.

Medi Caps Ltd's Board of Directors approved the audited standalone and consolidated financial results for the fourth quarter and financial year ended March 31, 2026. They also approved the re-appointment of Praveen Shrivastava & Company as the Internal Auditor for FY 2026-27. The board meeting was held on May 21, 2026, from 3:00 P.M. to 3:55 P.M.

Medi Caps Ltd has scheduled a Board of Directors meeting on May 21, 2026, to consider and approve the standalone and consolidated audited financial results for the fourth quarter and financial year ended March 31, 2026. The trading window will open 48 hours after the declaration of the results.

Medi Caps Ltd. has issued an intimation under Regulation 30 of SEBI (LODR) Regulation, 2015, urging shareholders holding shares in physical mode to mandatorily furnish their PAN, KYC, Bank details, and other required information. This update is essential for seamless communication, regulatory compliance, and direct credit of dividends. Shareholders are requested to update their PAN, Choice of Nomination, Contact Details, Mobile Number, Bank Account Details and Specimen Signature to the Registrar and Share Transfer Agent (RTA) of the Company.

Medi Caps Ltd. has announced that the Securities and Exchange Board of India (SEBI) has opened a special window for transfer and dematerialization of physical securities. This window is for securities sold or purchased before April 01, 2019, and it will remain open from February 05, 2026, to February 04, 2027. The securities transferred will be mandatorily credited to the transferee in demat mode and will be under lock-in for a period of one year from the date of registration of transfer. Shareholders are requested to furnish the required documents to the Company’s Registrar and Share Transfer Agents (RTA), Ankit Consultancy Private Limited, for this opportunity.

Medi Caps Ltd. has announced the closure of the trading window for all designated persons, their immediate relatives, and all connected persons from 1st April, 2026 until 48 hours after the declaration of the audited standalone and consolidated financial results for the quarter and financial year ended on 31st March, 2026. This decision is in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct. The trading window will open 48 hours after the results become generally available. All directors, KMP’s, designated employees, connected persons, fiduciaries, and their immediate relatives are advised not to deal in the securities of the Company during this period.

Medi Caps Ltd. has announced the unaudited standalone and consolidated financial results for the quarter and nine months ended 31.12.2025. The company's Board of Directors approved the financial results during a meeting held on 11th February 2026. The financial results will be submitted to the stock exchange in XBRL mode and will be available on the company's website and in newspapers.